Privacy Statement

This privacy statement discloses the privacy practices and restrictions for the PharmaDerm web site: www.pharmaderm.com.

Information Collection and Use:

PharmaDerm is the sole owner of the information collected through our web site. We do not sell or rent this information to others. PharmaDerm may collect statistical information on visitors to our web site, as well as personal information from users who voluntarily submit information to us.

Links:

This web site may contain links to other sites. Please be aware that PharmaDerm is not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of each and every web site that collects personally identifiable information.

Security:

This application takes every precaution to protect our users' information. When users submit sensitive information via our web site, the information is protected both online and off-line. Information submitted via our web site is encrypted with SSL software. While we use SSL encryption to protect sensitive information online, we also do everything in our power to protect user-information off-line. All of our users' information, not just the sensitive information mentioned above, is restricted in our offices.

Notification of Changes:

If we need to change our privacy policy, we will post the changes on our web site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.

Important Product Safety Information

OXISTAT® is approved for topical use in these skin infections:

  • OXISTAT® CREAM and OXISTAT® LOTION—for athlete's foot, jock itch and ringworm due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.
  • OXISTAT® CREAM—for tinea (pityriasis) versicolor due to Malassezia furfur.
  • OXISTAT® CREAM—for ringworm, jock itch and tinea (pityriasis) versicolor in children. Please note: these conditions are rare in children under age 12.

The most common side effects reported with OXISTAT® were itching and burning.

OXISTAT® CREAM and OXISTAT® LOTION are not for ophthalmic or intravaginal use.

For more information, consult your healthcare provider.
Please see the link to the Full Prescribing Information below.

OXISTAT® (oxiconazole nitrate) Cream & Lotion Full Prescribing Information